Loading stock data…
Loading stock data…
US$25.68
Get one email when AVLN crosses your level. Checked every 15 minutes during market hours.
▼ -1.72 (-6.28%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Biotechnology
Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company developing inhaled therapies for rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. Its pipeline features optimized inhaled formulations of established antifibrotic medicines, such as AP01, an inhaled version of pirfenidone for progressive pulmonary fibrosis, and AP02, an inhaled formulation of nintedanib for idiopathic pulmonary fibrosis. This nebulization approach aims to deliver medicat…
www.avalynpharma.com4 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (10 analysts, 2026-07-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-06-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-01 | 2.28 | 3.23 | ✓ Beat |
| 2026-05-11 | 0.41 | 0.52 | ✓ Beat |
Companies in the same industry, via Finnhub
RSI (14-day)
38.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.54
Bearish momentumMACD below its signal line (-0.11).
50-day average
28.70
Price belowShort-term trend reference.
Daily values · indicators are descriptive, not trading advice